Your browser doesn't support javascript.
loading
BCL6 promotes a stem-like CD8+ T cell program in cancer via antagonizing BLIMP1.
Sun, Qinli; Cai, Dongli; Liu, Dingfeng; Zhao, Xiaohong; Li, Ruifeng; Xu, Wei; Xie, Bowen; Gou, Mengting; Wei, Kun; Li, Yuling; Huang, Jinling; Chi, Xinxin; Wei, Peng; Hao, Jing; Guo, Xinyi; Pan, Birui; Fu, Yujie; Ni, Ling; Dong, Chen.
Afiliación
  • Sun Q; Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
  • Cai D; Shanghai Immune Therapy Institute, New Cornerstone Science Laboratory, Shanghai Jiao Tong University School of Medicine-Affiliated Renji Hospital, Shanghai 200127, China.
  • Liu D; Department of Gynaecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 201204, China.
  • Zhao X; Shanghai Immune Therapy Institute, New Cornerstone Science Laboratory, Shanghai Jiao Tong University School of Medicine-Affiliated Renji Hospital, Shanghai 200127, China.
  • Li R; Department of Gynaecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 201204, China.
  • Xu W; Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
  • Xie B; Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
  • Gou M; Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100084, China.
  • Wei K; Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
  • Li Y; Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100084, China.
  • Huang J; Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
  • Chi X; Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100084, China.
  • Wei P; Shanghai Immune Therapy Institute, New Cornerstone Science Laboratory, Shanghai Jiao Tong University School of Medicine-Affiliated Renji Hospital, Shanghai 200127, China.
  • Hao J; Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
  • Guo X; Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
  • Pan B; College of Life Science and Peking University-Tsinghua University-National Institute of Biological Sciences Joint Graduate Program, Tsinghua University, Beijing 100084, China.
  • Fu Y; Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
  • Ni L; Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
  • Dong C; Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
Sci Immunol ; 8(88): eadh1306, 2023 10 27.
Article en En | MEDLINE | ID: mdl-37862431

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Neoplasias Límite: Humans Idioma: En Revista: Sci Immunol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Neoplasias Límite: Humans Idioma: En Revista: Sci Immunol Año: 2023 Tipo del documento: Article País de afiliación: China